NCT01696461 - A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor | Biotech Hunter

Enrollment

127

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Related Donors Donating Peripheral Blood Stem Cells (PBSC) to a Family MemberAcute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic SyndromeChronic Myelogenous LeukemiaNon-Hodgkin's LymphomaHodgkin's DiseaseChronic Lymphocytic Leukemia

Interventions

DRUG

Plerixafor

Trial Locations (12)

Unknown

H. Lee Moffitt Cancer Center, Tampa

Emory University, Atlanta

University of Chicago, Chicago

Massachusetts General Hospital, Boston

University of Minnesota, Minneapolis

Mayo Clinic, Rochester

Washington University, St Louis

Duke University, Durham

Cleveland Clinic, Cleveland

Ohio State University, Columbus

West Virginia University, Morgantown

Medical College of Wisconsin, Milwaukee